We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Share News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.18
Ask: 0.20
Change: -0.01 (-5.00%)
Spread: 0.02 (11.111%)
Open: 0.20
High: 0.00
Low: 0.00
Prev. Close: 0.20
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

Thu, 24th Sep 2020 17:35

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Personal Group Holdings PLC - Milton Keynes-based employee benefits firm - Lands three-year contract extension with postal operator Royal Mail PLC to continue supplying Let's Connect salary sacrifice technology scheme. "Personal Group has developed a digital solution that will integrate into RMG's existing benefits platform, giving their entire workforce the ability to apply for insurance products online as well as via a traditional face-to-face and roadshow approach," the company said.

----------

Smartspace Software PLC - office space management software and hospitality and ticketing platform - Signs distribution deal with ESCO Pte Ltd, an audio visual integrator based in Singapore. Pact will see Smartspace resell its Space Connect workspace management solution. "Space Connect will be offered to ESCO's customers as a solution to help them enhance smart workplace strategies and implement Covid-related policies in the workplace, providing tools to assist with social distancing, screening of employees and visitors, recording of sanitisation, room and desk booking and Covid-specific employee communications," Smartspace said.

----------

SpaceandPeople PLC - Glasgow-based retail, promotional and brand experience firm - Granted extension to report interim results for six months to June 30. Expects to announce results by October 16.

----------

VR Education Holdings PLC - Waterford, Ireland-based virtual reality education and enterprise training - Launches Showcase Experience, Shuttle Commander flight simulator on Facebook Inc's Oculus Quest platform.

----------

BigDish PLC - Jersey-based reservations, delivery and pick up platform for restaurants - Signs letter of intent with a Central European investment group for USD5 million investment. Investment hinges on company completing technology audit and restaurant acceptance of BigDish-to-Go platform. Notes Non-Executive Director Simon Perree to step down to launch "new business venture".

----------

Bango PLC - Cambridge-based mobile payments company - Lands partnership with customer-lifecycle management platform Evergent, based in Silicon Valley. "Through this partnership, Evergent customers can deliver a simplified consumer journey, by easily launching multiple merchants integrated to Bango, which include Google, Amazon and Spotify. This global partnership strengthens the joint value proposition offered by Evergent and Bango, for both media companies and telcos to boost user acquisition, strengthen retention, and grow revenues," Bango said.

----------

Escape Hunt PLC - escape rooms operator - Says trading at UK-owner operated stores "encouraging" since July 12 reopening. Pace of sales growth has slowed in recent weeks, as expected, though in six weeks to September 20, sales up 72% annually.

----------

Character Group PLC - Surrey-based toymaker - Says second half of year to August 31, "considerably affected" by lockdown measures in UK but still expects profit for six-month period to be at least equal to first half. "Demand for the group's exciting and innovative products has remained resilient throughout the year, and the board is confident that steady progress will continue to be made through to Christmas 2020 and into 2021. As always at this time of year, development of the group's ranges and products for the Christmas season 2021 is well advanced and early feedback from customers to our previews and presentations have been extremely gratifying," Character added.

----------

WANdisco PLC - data-management software company in Sheffield - Lands agreement with digital services and consulting firm Infosys. Deal will see duo help companies migrate data to major public clouds such as Amazon.com Inc's Amazon Web Services, Microsoft Corp's Azure and Alphabet Inc's Google cloud.

----------

IXICO PLC - neuroscience data analytics firm - Enters into five-year agreement with non-profit organisation Friedreich's Ataxia Research Alliance. Venture will seek to find treatments for friedreich's ataxia, a genetic disease which can cause a loss of feeling in arms and legs. "IXICO will become a member of the TRACK-FA Neuroimaging Consortium, working with clinicians and researchers to explore novel imaging markers in Friedreich's Ataxia," IXICO said.

----------

OPG Power Ventures PLC - Indian power plant operator - Has applied for two-month extension to report annual results. Now expects to publish annual report in second half of October.

----------

Verditek PLC - London-based solar panel manufacturer - Secures first order from Australian mining sector. Pens order to provide solar power to InterGroup Mining Ltd exploration work in Queensland.

----------

Gore Street Energy Storage Fund PLC - energy storage fund - Says net asset value per share at June 30 up 1.7% to 96.2 pence from 94.6p at end of March. "The increase in the latest quarterly NAV is attributable to both the strong performance of the company's UK assets, recent acquisitions and ongoing progress in the construction of the company's Irish assets, these continue to progress in-line with the anticipated completion schedules," Gore Street said.

----------

Braveheart Investment Group PLC - Barnsely, England-based strategic investor - Investee Phasefocus Holdings Ltd seeing demand for original equipment sales and long-term service contracts. Braveheart owns 43% stake in Phasefocus.

----------

Mercia Asset Management PLC - regionally-focused asset manager - Says balance sheet portfolio showing "increasing momentum" as companies in life sciences and software sector thriving, and those in industries badly hurt by Covid-19 are now recovering.

----------

JPMorgan Global Core Real Assets Ltd - investment company - Says USD75.7 million of committed capital has been called, with funding date of October 1 the latest. "This capital is being called by two of the higher-yielding underlying strategies; the Global Core Infrastructure and Global Transport Income strategies," trust explains. "The manager continues to see attractive opportunities in real assets across the JPMorgan Asset Management Alternatives Platform and the company will seek to raise further equity as client demand and market opportunities present themselves."

----------

U&I Group PLC - real estate regeneration development firm - Making positive progress in planning permission for GBP200 million scheme at Tunbridge Wells, Kent. "All planning matters have been addressed by the planning committee and the scheme is only subject to the resolution of Highways Mitigation measures and completion of the standard procedural and judicial review process," U&I said.

----------

Cora Gold Ltd - West Africa-focused gold company - Reports results from metallurgical testworks at Sanankoro gold project in Mali. Says average overall recovery of just ovver 94% was achieved. "The results from this metallurgical test programme are excellent. A significant proportion of the gold in the Sanankoro ore can be recovered with gravity with over 90% of the remaining gold leaching from the gravity tails within 4 hours," Chief Executive Bert Monro.

----------

Atalaya Mining PLC - Cyprus-based copper producer - Starts permitting process for development of 50 megawatt solar plant at Proyecto Riotinto, Spain. Says solar plant will cut costs as well as emissions.

----------

TomCo Energy PLC - US operating oil development group - Says work to boost capacity and reliability at oil sands project in Asphalt Ridge, Utah has kicked off. Restart of the plant expected in November. Plans to boost capacity to 400 barrels of oil per day and decrease incremental cost per barrel.

----------

Castillo Copper Ltd - Australia and Zambia focused base metal explorer - Says 24 assayed rock chips from Big One deposit, Greenland confirm "existence of high-grade copper mineralisation". "Teams from Castillo and Depco Drilling are targeting drilling work to commence in October 2020," Castillo said.

----------

Oriole Resources PLC - exploration company with operations in Senegal and Cameroon - Signs contract with Capital Ltd for 3,000 metres worth of drilling at Bibemi exploration licence in Cameroon.

----------

Canadian Overseas Petroleum Ltd - oil and gas exploration and development company focused on offshore Africa - Confident it will receive exploration licence extension at OPL 226, Nigeria by during fourth quarter.

----------

ECR Minerals PLC - Australia-focused gold explorer - Has applied for two new exploration licences in Victoria, Australia which will form part of Tambo gold project.

----------

Trident Royalties PLC - London-based mining royalty firm - Enters into agreement to acquire existing gold royalty at Lake Rebecca gold project, Australia. Trident pays AUD8.0 million, about USD5.6 million for 1.5% net smelter royalty.

----------

Block Energy PLC - exploration and production in Georgia - Says early production facility installed

at WR-16aZ well site in West Rustavi, Georgia. Says acquisition of Schlumberger Rustaveli Co Ltd progressing.

----------

Nuformix PLC - pharmaceutical development firm - Signs exclusive option agreement with Oxilio Ltd for development and exploitation of NXP001 in oncology. Nuformix to get upfront payment for six-month exclusive option and should Oxilio exercise option, "Nuformix will licence its patent estate and know-how on NXP001 in return for a significant upfront payment and additional development milestones and a royalty on net sales," company explained. Royalty to be capped at GBP2 million per year.

----------

Open Orphan PLC - pharmaceutical services company - Notes share price movement and press reports on UK government-funded Coronavirus human challenge studies. Open Orphan in talks with UK government and other partners for challenge study. Should contract be agreed, revenue will rise by GBP7 million.

----------

Mereo BioPharma Group PLC - London-based biopharmaceutical firm - Says US Food & Drug Administration grants rare pediatric disease designation to setrusumab for treatment of osteogenesis imperfecta, a bone disease.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
12 Mar 2024 14:30

UK shareholder meetings calendar - next 7 days

Wednesday 13 March 
abrdn China Investment Co LtdGM re liquidation
Safestore Holdings PLCAGM
Wincanton PLCGM re takeover by CEVA Logistics
Thursday 14 March 
Angus Energy PLCGM
Bank of Georgia Group PLCGM re acquisition of Ameriabank CJSC
Blackrock Sustainable American Income Trust PLCAGM
Friday 15 March 
BlackRock Energy & Resources Income Trust PLCAGM
Chrysalis Investments LtdAGM
Quantum Exponential Group PLCGM re delisting from AQSE
TruSpine Technologies PLCAGM (adjourned 2022)
United Oil & Gas PLCGM re fundraise and share sub-division
Monday 18 March 
MGC Pharmaceuticals LtdGM re change of company name to Argent Biopharma
Schroder European Real Estate Investment Trust PLCAGM
Tuesday 19 March 
BlackRock Throgmorton Trust PLCAGM
Crest Nicholson Holdings PLCAGM
Eco Animal Health Group PLCGM re share buybacks
Gresham House Renewable Energy VCT 1 PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
Nuformix PLCAGM
Scirocco Energy PLCGM re requisitioned resolution to implement cash strategy
Various Eateries PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
1 Mar 2024 10:31

IN BRIEF: Nuformix announces subscription to raise GBP150,000

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross proceeds of GBP150,000 through a subscription for 75.0 million new shares at a price of 0.20 pence each. The shares will represent 9.2% of Nuformix's enlarged issued share capital. Company will use the subscription's net proceeds primarily to further advance its NXP002 programme for the inhaled treatment of idiopathic pulmonary fibrosis.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
23 Oct 2023 12:38

Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002

(Alliance News) - Nuformix PLC on Monday said it has been issued with a patent in Japan for NXP002, its potential novel inhaled treatment for idiopathic pulmonary fibrosis.

Read more
18 Sep 2023 10:20

IN BRIEF: Nuformix to receive milestone payments from Oxilio pact

Nuformix PLC - London-based pharmaceutical development company targeting unmet medical needs in fibrosis and oncology - Says it will receive immediate and near-term milestone payments as part of an update to its NXP001 exclusive licensing agreement with Oxilio Ltd. Nuformix does not disclose any financial details on this. Under the revised agreement, says Oxilio will acquire ownership of Nuformix's NXP001 patent estate. Says it will receive the additional milestone payments while retaining further development milestones and royalties capped at GBP2 million per year.

Read more
17 Aug 2023 15:43

UK shareholder meetings calendar - next 7 days

Friday 18 August 
Adams PLCAGM
ME Group International PLCGM re proposed share buyback
Oxford BioDynamics PLCGM re placing
Pathfinder Minerals PLCGM re disposal of the subsidiary
Monday 21 August 
Calculus VCT PLCAGM
Home REIT PLCGM re changes to the investment policy
Tuesday 22 August 
Cake Box Holdings PLCAGM
ReNeuron Group PLCAGM
RUA Life Sciences PLCAGM
Smoove PLCAGM
STM Group PLCAGM
Wednesday 23 August 
Brandshield Systems PLCAGM
James Latham PLCAGM
LifeSafe Holdings PLCGM re shareholder circular
Momentum Multi-Asset Value Trust PLCGM re appointment of the liquidators
Sovereign Metals LtdGM re share placement options
Thor Energy PLCGM re proposed share consolidation
Thursday 24 August 
Ananda Developments PLCAGM
Concurrent Technologies PLCAGM
CyanConnode Holdings PLCAGM
Nuformix PLCAGM
Oryx International Growth Fund LtdAGM
ThomasLloyd Energy Impact Trust PLCAGM
ThomasLloyd Energy Impact Trust PLCGM re market purchases of its own ordinary shares
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
22 May 2023 12:45

Nuformix loss narrows; near-term goal to focus on NXP002 asset

(Alliance News) - Nuformix PLC on Monday reported a narrowed annual loss as it made progress on optimising costs and furthering its lead asset, NXP002.

Read more
18 May 2023 14:31

TRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effect

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
17 Apr 2023 12:14

Nuformix raises GBP70,000 to fund NXP002 programme

(Alliance News) - Nuformix PLC on Monday said it has raised GBP70,000 through a subscription for 35.0 million new shares at a price of 0.20 pence each.

Read more
27 Mar 2023 18:42

TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
15 Feb 2023 12:12

Nuformix progresses NXP002 trial after acquiring human tissue

(Alliance News) - Nuformix PLC on Wednesday said that, despite having to wait longer than expected, human disease tissue has now been acquired for its NXP002 programme.

Read more
13 Dec 2022 14:54

Nuformix interim loss virtually flat as continues work on drugs

(Alliance News) - Nuformix PLC on Tuesday reported a negligibly smaller half-year loss as it continued to work on treatments for cancer and fibrosis, a disease which scars tissues in the lungs.

Read more
23 Sep 2022 21:02

TRADING UPDATES: Neometals swings to loss; Funding Circle strikes deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
18 Aug 2022 16:01

UK shareholder meetings calendar - next 7 days

Friday 19 August 
Braemar Shipping Services PLCAGM
Citius Resources PLCAGM
Next Fifteen Communications Group PLCGM re acquisition of M&C Saatchi
Volex PLCAGM
Monday 22 August 
African Pioneer PLCAGM
Argentex Group PLCAGM
Nostrum Oil & Gas PLCGM operational update
Ondo InsurTech PLCAGM
Sabien Technology Group PLCGM re broker option
Scottish Investment Trust PLCGM re recombination of assets with JPMorgan Global Growth & Income plc
Trackwise Designs PLCAGM
Tuesday 23 August 
Bezant Resources PLCAGM
Livermore Investments Group LtdAGM
Xtract Resources PLCAGM
Wednesday 24 August 
Amur Minerals CorpGM subsidiary sale
Creightons PLCAGM
Goldstone Resources LtdAGM
Thursday 25 August 
Ince Group PLCGM fundraising
McBride PLCGM increase in borrowing limit
NatWest Group PLCGM re approval of special dividend
Nuformix PLCAGM
Triple Point Energy Efficiency Infrastructure Co PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
10 Aug 2022 11:14

IN BRIEF: Nuformix shares rise on tolerability studies completion

Nuformix PLC - London-based pharmaceutical firm targeting fibrosis and oncology - Says NXP002, a potential treatment for idiopathic pulmonary fibrosis, has successfully completed pre-clinical tolerability studies. "Tolerability has been demonstrated across a new range of doses, including higher doses than previously given," it explains. Work now commences to explore how the new doses studied can best optimise efficacy and the treatment's positive pharmacological profile.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.